Performance of the High-STEACS Early Rule Out Pathway Using hs-cTnT at 30 Days in a Multisite US Cohort
Circulation: Cardiovascular Quality and Outcomes · 2025-02 · 18 (2)
DOI: 10.1161/circoutcomes.124.011084 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2025-02. Verfasst von Nicklaus P Ashburn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine (N.P.A., A.C.S., M.W.S., M.J.M., T.H., S.A.M.), Wake Forest University School of Medicine, Winston-Salem, NC. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Decision Support Techniques, Troponin T. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, AHRQ HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: The High-STEACS (High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome) pathway risk stratifies emergency department patients with possible acute coronary syndrome. This study aims to determine if the High-STEACS hs-cTnT (high-sensitivity cardiac troponin T) pathway can achieve the ≥99% negative predictive value (NPV) safety threshold for 30-day cardiac death or myocardial infarction (CDMI) in a multisite US cohort of patients with and without known coronary artery disease (CAD). METHODS: A secondary analysis of the STOP-CP (High-Sensitivity Cardiac Troponin T [Gen 5 STAT Assay] to Optimize Chest Pain Risk Stratification) cohort, which enrolled adult emergency department patients with possible acute coronary syndrome at 8 US sites (January 25, 2017–September 6, 2018). Participants were classified into outpatient and admission dispositions using the High-STEACS hs-cTnT pathway. Known CAD was defined as prior MI, coronary revascularization, or ≥70% coronary stenosis. Outcomes included 30-day CDMI and efficacy, defined as the proportion identified for outpatient disposition. NPVs and negative likelihood ratios for 30-day CDMI were calculated. NPVs were compared between CAD subgroups using a Fisher exact test. RESULTS: Among 1351 patients, 53.2% (719/1351) were male, 31.4% (424/1351) had known CAD, and the mean age was 57.4±12.8 years. At 30 days, CDMI occurred in 13.8% (187/1351). High-STEACS classified 63.4% (857/1351) to outpatient disposition, of which 2.0% (17/857) had 30-day CDMI, corresponding to an NPV of 98.0% (95% CI, 96.8–98.8) and negative likelihood ratio of 0.13 (95% CI, 0.08–0.20). In patients with CAD, 46.9% (199/424) were classified to outpatient disposition, of which 4.0% (8/199) had 30-day CDMI. Among patients without CAD, 71.0% (658/927) were classified to outpatient disposition with 1.4% (9/658) having 30-day CDMI. The NPV for 30-day CDMI was 96.0% (95% CI, 92.2–98.2) in patients with CAD versus 98.6% (95% CI, 97.4–99.4) among patients without CAD ( P =0.04). The negative likelihood ratio for 30-day CDMI among patients with CAD was 0.16 (95% CI, 0.08–0.31) and 0.12 (95% CI, 0.06–0.22) among patients without CAD. CONCLUSIONS: The High-STEACS hs-cTnT pathway had high efficacy but was unable to achieve the ≥99% NPV safety threshold for 30-day CDMI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02984436.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine (N.P.A., A.C.S., M.W.S., M.J.M., T.H., S.A.M.), Wake Forest University School of Medicine, Winston-Salem, NC.
- Department of Biostatistics and Data Science (A.C.S.), Wake Forest University School of Medicine, Winston-Salem, NC.
- Department of Emergency Medicine, University of Florida College of Medicine, Gainesville (B.R.A.).
- Department of Pathology (R.H.C.), University of Maryland School of Medicine, Baltimore.
- Department of Emergency Medicine, University of Utah School of Medicine, Salt Lake City (T.M.).
- Department of Emergency Medicine, University of California Davis School of Medicine, Sacramento (B.E.M.).
ORCID-Profile: Nicklaus P Ashburn, Anna C Snavely, Michael W Supples, Marissa J Millard, Brandon R Allen, Robert H Christenson, Bryn E Mumma, R Gentry Wilkerson, Simon A Mahler
Förderung
- NHLBI NIH HHS
- AHRQ HHS
- NCATS NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Ashburn, N. P., Snavely, A. C., Supples, M. W., Millard, M. J., Allen, B. R., Christenson, R. H., Madsen, T., Mumma, B. E., Hashemian, T., Wilkerson, R. G., & Mahler, S. A. (2025). Performance of the High-STEACS Early Rule Out Pathway Using hs-cTnT at 30 Days in a Multisite US Cohort. Circulation: Cardiovascular Quality and Outcomes, 18(2). https://doi.org/10.1161/circoutcomes.124.011084
Vancouver
Ashburn NP, Snavely AC, Supples MW, Millard MJ, Allen BR, Christenson RH, et al. Performance of the High-STEACS Early Rule Out Pathway Using hs-cTnT at 30 Days in a Multisite US Cohort. Circulation: Cardiovascular Quality and Outcomes. 2025;18(2). doi:10.1161/circoutcomes.124.011084
BibTeX
@article{Ashburn2025,
author = {Ashburn, Nicklaus P and Snavely, Anna C and Supples, Michael W and Millard, Marissa J and Allen, Brandon R and Christenson, Robert H and Madsen, Troy and Mumma, Bryn E and Hashemian, Tara and Wilkerson, R Gentry and Mahler, Simon A},
title = {Performance of the High-STEACS Early Rule Out Pathway Using hs-cTnT at 30 Days in a Multisite US Cohort},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2025},
volume = {18},
number = {2},
doi = {10.1161/circoutcomes.124.011084}
}
EUVIMED